- Home
- ARDX vs TFIN Comparison
ARDX vs TFIN Comparison
Compare ARDX & TFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARDX
- TFIN
- Stock Information
- Founded
- ARDX 2007
- TFIN 1981
- Country
- ARDX United States
- TFIN United States
- Employees
- ARDX N/A
- TFIN N/A
- Industry
- ARDX Biotechnology: Pharmaceutical Preparations
- TFIN Major Banks
- Sector
- ARDX Health Care
- TFIN Finance
- Exchange
- ARDX Nasdaq
- TFIN Nasdaq
- Market Cap
- ARDX 1.3B
- TFIN 1.5B
- IPO Year
- ARDX 2014
- TFIN N/A
- Fundamental
- Price
- ARDX $4.79
- TFIN $57.51
- Analyst Decision
- ARDX Strong Buy
- TFIN Hold
- Analyst Count
- ARDX 9
- TFIN 6
- Target Price
- ARDX $10.61
- TFIN $77.50
- AVG Volume (30 Days)
- ARDX 3.9M
- TFIN 198.8K
- Earning Date
- ARDX 05-01-2025
- TFIN 04-16-2025
- Dividend Yield
- ARDX N/A
- TFIN N/A
- EPS Growth
- ARDX N/A
- TFIN N/A
- EPS
- ARDX N/A
- TFIN 0.54
- Revenue
- ARDX $333,615,000.00
- TFIN $396,285,000.00
- Revenue This Year
- ARDX $14.26
- TFIN $17.60
- Revenue Next Year
- ARDX $32.49
- TFIN $12.72
- P/E Ratio
- ARDX N/A
- TFIN $105.52
- Revenue Growth
- ARDX 168.06
- TFIN N/A
- 52 Week Low
- ARDX $4.32
- TFIN $56.50
- 52 Week High
- ARDX $9.33
- TFIN $110.58
- Technical
- Relative Strength Index (RSI)
- ARDX 37.46
- TFIN 29.36
- Support Level
- ARDX $4.68
- TFIN $60.76
- Resistance Level
- ARDX $5.56
- TFIN $65.64
- Average True Range (ATR)
- ARDX 0.25
- TFIN 2.76
- MACD
- ARDX -0.05
- TFIN 0.19
- Stochastic Oscillator
- ARDX 12.71
- TFIN 11.05
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.
About TFIN Triumph Financial Inc.
Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.